Entity family
Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.
This drug is selected. Its supporting articles are shown below.
…lt, sustained clinical responses to existing therapies, such as tyrosine kinase inhibitors, anti-angiogenic agents and immune checkpoint inhibitors, remai…
…wing chemoradiation in unresectable stage III disease, adjuvant tyrosine kinase inhibitors in resected epidermal growth factor receptor/anaplastic lymphom…
…on of tyrosine kinases, such as EGFR, VEGFR, and PDGFRa, making tyrosine kinase inhibitors (TKIs) a potential treatment option. Although preclinical studi…
… in treating advanced NSCLC is the development of resistance to tyrosine kinase inhibitors (TKIs), highlighting the need to comprehensively profile the ce…
…Background Current treatments with tyrosine kinase inhibitors and immune checkpoint inhibitors have limited efficacy for hepa…
… deterioration can occur. Case reports of patients treated with tyrosine kinase inhibitors (TKIs) suggest that these drugs may be a therapeutic option in …
… performed among patients on oral anticancer medication (mainly tyrosine kinase inhibitors, (anti)hormonal therapy, pyrimidine antagonists) using a semi-s…